CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
duloxetine hydrochloridedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00191061
NCT00191061Phase 4Completed
CompareCT.gov

A Comparison of Duloxetine Dosing Strategies in The Treatment of Patients With Major Depression

Eli Lilly and Company·interventional·Posted Sep 19, 2005·Updated Jan 26, 2007

In Brief

A Phase 4 clinical trial evaluating duloxetine hydrochloride for Depressive Disorder. Completed, across 32 sites.

Detailed Summary

The purpose of this study is to compare the tolerability and efficacy of different doses of duloxetine in patients with major depressive disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepressive Disorder
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 19, 2005
Enrollment StartOct 1, 2004
Study CompletionJan 1, 2006
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

duloxetine hydrochloridedrug